Stock listing
Dusseldorf:BT3 Lineage Cell Therapeutics, Inc. Aktie
German listing (Dusseldorf) of Lineage Cell Therapeutics, Inc. · home listing NYSE American:LCTX
Follow Lineage Cell Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · AMEX:LCTX
$1.00 USD -0.03 (-2.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:LCTX
- Day range
- $0.982 – $1.05 USDOct 30, 2026
- Volume
- 1.17M sharesOct 30, 2026
- Market cap
- $252.9M USDAt the close on Oct 30, 2026 · price × 252.9M shares outstanding
- 52-week range
- $0.88 – $2.09 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.27M USDMedian day 1.12M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:LCTX · Home | $1.00 USD | -0.03 (-2.9%) | 1,166,435 | $1.04 | $1.05 | $0.982 | $1.03 | Close on Oct 30, 2026 |
| TASE:LCTX | 300.40 ILA (agorot) | -0.10 (0.0%) | 19,059 | 300.50 | 300.90 | 290.00 | 300.50 | Close on Oct 22, 2026 |
| Frankfurt:BT3 | €0.904 EUR | +0.025 (+2.8%) | — | €0.904 | €0.904 | €0.904 | €0.879 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:LCTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.00 | -0.03 | -2.9% | $1.04 | $1.05 | $0.982 | 1,166,435 | |
| $1.03 | -0.01 | -1.0% | $1.05 | $1.06 | $1.02 | 937,707 | |
| $1.04 | +0.01 | +1.0% | $1.03 | $1.045 | $1.01 | 1,076,858 | |
| $1.03 | +0.033 | +3.3% | $0.993 | $1.04 | $0.975 | 1,194,494 | |
| $0.997 | -0.003 | -0.3% | $1.00 | $1.01 | $0.964 | 1,907,527 | |
| $1.00 | +0.01 | +1.0% | $0.97 | $1.02 | $0.94 | 1,150,100 | |
| $0.99 | +0.04 | +4.2% | $0.95 | $1.01 | $0.94 | 1,346,600 | |
| $0.95 | -0.02 | -2.1% | $0.99 | $0.99 | $0.94 | 1,220,800 | |
| $0.97 | +0.02 | +2.1% | $0.95 | $1.01 | $0.95 | 1,631,200 | |
| $0.95 | -0.03 | -3.1% | $0.98 | $1.00 | $0.94 | 955,500 | |
| $0.98 | -0.01 | -1.0% | $0.98 | $1.00 | $0.96 | 1,308,700 | |
| $0.99 | +0.07 | +7.6% | $0.92 | $1.00 | $0.92 | 1,415,000 | |
| $0.92 | +0.01 | +1.1% | $0.91 | $0.94 | $0.89 | 2,201,200 | |
| $0.91 | -0.04 | -4.2% | $0.95 | $0.97 | $0.90 | 1,784,700 | |
| $0.95 | -0.04 | -4.0% | $1.00 | $1.00 | $0.94 | 1,687,000 | |
| $0.99 | -0.04 | -3.9% | $1.02 | $1.03 | $0.98 | 1,158,500 | |
| $1.03 | +0.08 | +8.4% | $0.95 | $1.05 | $0.93 | 2,009,800 | |
| $0.95 | +0.012 | +1.3% | $0.94 | $0.97 | $0.92 | 1,476,400 | |
| $0.938 | +0.01 | +1.1% | $0.941 | $0.965 | $0.925 | 967,620 | |
| $0.927 | -0.003 | -0.3% | $0.93 | $0.96 | $0.912 | 1,386,588 | |
| $0.93 | +0.03 | +3.3% | $0.92 | $0.96 | $0.89 | 1,249,300 | |
| $0.90 | -0.06 | -6.2% | $0.96 | $0.97 | $0.88 | 1,651,900 | |
| $0.96 | +0.01 | +1.1% | $0.95 | $0.99 | $0.94 | 1,267,800 | |
| $0.95 | -0.02 | -2.1% | $0.98 | $0.99 | $0.92 | 2,592,100 | |
| $0.97 | -0.06 | -5.8% | $1.02 | $1.04 | $0.96 | 1,574,200 | |
| $1.03 | +0.08 | +8.4% | $0.95 | $1.04 | $0.94 | 2,481,300 | |
| $0.95 | -0.01 | -1.0% | $0.95 | $0.97 | $0.91 | 2,439,900 | |
| $0.96 | -0.08 | -7.7% | $1.02 | $1.04 | $0.96 | 2,630,200 | |
| $1.04 | +0.03 | +3.0% | $1.02 | $1.05 | $1.00 | 846,800 | |
| $1.01 | -0.02 | -1.9% | $1.03 | $1.05 | $1.01 | 720,700 | |
| $1.03 | 0.00 | 0.0% | $1.02 | $1.06 | $1.00 | 3,209,200 | |
| $1.03 | -0.04 | -3.7% | $1.10 | $1.10 | $1.03 | 894,400 | |
| $1.07 | +0.01 | +0.9% | $1.06 | $1.12 | $1.03 | 1,639,500 | |
| $1.06 | -0.01 | -0.9% | $1.06 | $1.07 | $1.02 | 1,399,500 | |
| $1.07 | +0.06 | +5.9% | $1.01 | $1.08 | $1.01 | 1,840,100 | |
| $1.01 | -0.01 | -1.0% | $1.02 | $1.03 | $1.00 | 910,400 | |
| $1.02 | -0.01 | -1.0% | $1.02 | $1.03 | $1.00 | 1,197,700 | |
| $1.03 | -0.06 | -5.5% | $1.11 | $1.12 | $1.03 | 1,361,100 | |
| $1.09 | +0.01 | +0.9% | $1.10 | $1.16 | $1.09 | 1,312,122 | |
| $1.08 | -0.02 | -1.8% | $1.09 | $1.11 | $1.08 | 535,700 | |
| $1.10 | -0.01 | -0.9% | $1.11 | $1.12 | $1.09 | 916,500 | |
| $1.11 | +0.03 | +2.8% | $1.08 | $1.14 | $1.08 | 675,900 | |
| $1.08 | -0.02 | -1.8% | $1.10 | $1.12 | $1.08 | 902,700 | |
| $1.10 | -0.01 | -0.9% | $1.11 | $1.13 | $1.10 | 580,400 | |
| $1.11 | -0.05 | -4.3% | $1.16 | $1.18 | $1.11 | 587,300 | |
| $1.16 | +0.04 | +3.6% | $1.11 | $1.19 | $1.10 | 970,100 | |
| $1.12 | -0.01 | -0.9% | $1.16 | $1.16 | $1.10 | 800,200 | |
| $1.13 | +0.04 | +3.7% | $1.08 | $1.13 | $1.08 | 1,032,109 | |
| $1.09 | +0.01 | +0.9% | $1.08 | $1.11 | $1.06 | 607,680 | |
| $1.08 | 0.00 | 0.0% | $1.09 | $1.11 | $1.07 | 716,400 | |
| $1.08 | -0.02 | -1.8% | $1.09 | $1.10 | $1.04 | 1,474,300 | |
| $1.10 | +0.04 | +3.8% | $1.09 | $1.13 | $1.08 | 951,500 | |
| $1.06 | 0.00 | 0.0% | $1.06 | $1.08 | $1.05 | 1,112,400 | |
| $1.06 | -0.01 | -0.9% | $1.07 | $1.11 | $1.06 | 795,400 | |
| $1.07 | +0.01 | +0.9% | $1.06 | $1.09 | $1.05 | 1,129,400 | |
| $1.06 | -0.04 | -3.6% | $1.11 | $1.12 | $1.05 | 957,600 | |
| $1.10 | -0.02 | -1.8% | $1.12 | $1.13 | $1.09 | 698,000 | |
| $1.12 | -0.01 | -0.9% | $1.13 | $1.15 | $1.10 | 763,800 | |
| $1.13 | +0.03 | +2.7% | $1.10 | $1.15 | $1.09 | 752,300 | |
| $1.10 | -0.03 | -2.7% | $1.10 | $1.14 | $1.08 | 833,600 | |
| $1.13 | -0.01 | -0.9% | $1.16 | $1.18 | $1.12 | 711,600 | |
| $1.14 | +0.02 | +1.8% | $1.12 | $1.15 | $1.10 | 693,100 | |
| $1.12 | +0.01 | +0.9% | $1.13 | $1.15 | $1.11 | 860,800 | |
| $1.11 | +0.03 | +2.8% | $1.08 | $1.12 | $1.07 | 680,700 | |
| $1.08 | -0.03 | -2.7% | $1.11 | $1.13 | $1.07 | 948,700 | |
| $1.11 | +0.05 | +4.7% | $1.06 | $1.13 | $1.05 | 1,050,100 |
- Ticker
- Dusseldorf:BT3
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Lineage Provides Update on ReSonance® Program for Hearing Loss
Latest earnings call · Aug 6, 2026
Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 49 slides
Calls
Replays
Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptLineage Cell Therapeutics (NYSE American: LCTX) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch TranscriptLineage Cell Therapeutics (NYSE American: LCTX) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Lineage Provides Update on ReSonance® Program for Hearing Loss
Oct 29, 2026
Closed $1.03 (-1.0%) on Oct 29, 2026
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Sep 8, 2026
Closed $1.09 (+0.9%) on Sep 8, 2026
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026
Closed $1.10 (-2.7%) on Aug 7, 2026
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
Jul 30, 2026
Closed $1.11 (+4.7%) on Jul 30, 2026
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
Jul 13, 2026
Closed $1.21 (-5.5%) on Jul 13, 2026
Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
Jul 6, 2026
Closed $1.33 (-1.5%) on Jul 6, 2026
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Closed $1.28 (-3.8%) on May 13, 2026
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
May 5, 2026
Closed $1.46 (+2.8%) on May 5, 2026
OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
May 4, 2026
Closed $1.42 (-7.2%) on May 4, 2026
Lineage Announces Formation of Scientific Advisory Board
Apr 13, 2026
Closed $1.51 (+2.0%) on Apr 13, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 49 slides · Sep 14, 2026
Retinal Innovation Summit 2026
Conference · 22 slides · 2026
Q1 2025 Earnings Presentation
Earnings · 38 slides · May 13, 2025
Q4 2024 Earnings Presentation
Earnings · 43 slides · Mar 10, 2025
Lineage Cell Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 31 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Aug 6, 2026
- Decks
- 21 decks · latest Sep 14, 2026
Where Lineage Cell Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:LCTX · Home listing | NYSE American | United States | USD |
| TASE:LCTX | TASE | Israel | ILA |
| gettex:BT3 | gettex | Germany | EUR |
| LS Exchange:A2PP89 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PP89 | Lang & Schwarz | Germany | EUR |
| BOATS:LCTX | BOATS | United States | USD |
| Frankfurt:BT3 | Frankfurt | Germany | EUR |
| Tradegate:BT3 | Tradegate | Germany | EUR |
| Dusseldorf:BT3 · This page | Dusseldorf | Germany | EUR |
| Stuttgart:BT3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Lineage Cell Therapeutics, Inc.